ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
University of Birmingham at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
University of Birmingham brings 3 presentations to ACR Convergence 2026 in Orlando. Its program covers new therapies for Sjögren's disease and who might benefit most from them, stromal targets for CAR-T cells, and a network meta-analysis of injectable treatments for lateral epicondylitis.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
University of Birmingham Birmingham, UK | |
A public research university in England. | Talk Mon Nov 9 8:30am–9:00am Identifying Patients Who Might Benefit Most from New Sjögren's Disease Therapies Talk Tue Nov 10 8:30am–9:00am Stromal Targets for CAR-T Cells Poster Tue Nov 10 10:30am–12:30pm |
Find decision makers at University of Birmingham
Tell us what you sell and we’ll find the people at University of Birmingham most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction